Publications
25
Citations
151
Est. group size
~17
Recurring co-author estimate
Active years
12
Publishing since 2015
Danielle Elise Zimmerman is an oncology researcher whose work spans clinical studies of cancer treatments, including bladder/urothelial, prostate, kidney (renal cell), and breast cancers, alongside topics like immunotherapy, drug combinations, and cancer care delivery (such as managing treatment side effects and COVID-19 mitigation for cancer patients). Her publications also touch on adjacent areas such as skin drug reactions and health-related misinformation detection using computational methods. This suggests a research profile combining clinical oncology practice with broader interests in patient safety, health communication, and translational cancer biology.
Publication output was low and sporadic from 2017-2022 but has increased notably since 2023, with the highest output occurring in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Feasibility and Acceptability of a Multilayered COVID-19 Mitigation Intervention for Adults With Cancer
JAMA Network Open · 2026
- Abstract 4244: Application of a membrane interactomics (MInt) platform for novel surface target discovery
Cancer Research · 2025
- Detecting science-based health disinformation: a stylometric machine learning approach
Journal of Computational Social Science · 2023
- Abstract 3260: Potentiation of Type I interferon signaling leads to <i>in vivo</i> efficacy achieved with combination of chemotherapy and the PARP7 inhibitor RBN-2397
Cancer Research · 2023
- Enfortumab vedotin in FGFR3-mutated advanced urothelial carcinoma.
Journal of Clinical Oncology · 2021
- Abstract P2-18-04: Endocrine therapy (ET) and radiotherapy (RT) use among elderly women with hormone receptor positive (HR+), clinically node negative (cN-) breast cancer
Cancer Research · 2020
- Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)
2019
- Simulated patient encounter to assess and improve fellows' ability to manage chemotherapy infusion reactions.
Journal of Clinical Oncology · 2019
- Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)
2018
- Journal of Clinical Oncology×15
- Cancer Research×3
- Journal of Computational Social Science×1
- JCO Precision Oncology×1
- JAMA Network Open×1
- Amir Mortazavi
Medicine · The Ohio State University
- Shang-Jui Wang
Medicine · The Ohio State University
- Ming Yin
Medicine · The Ohio State University
- Debra L. Zynger
Medicine · The Ohio State University
- Debasish Sundi
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile